We were honored to welcome a distinguished delegation from Almoosa Health Group from Saudi Arabia to Jiahui International Hospital this week, led by CEO Dr. Malek Almoosa, alongside senior leaders across supply chain, portfolio management, procurement, and contract management.

The visit provided a valuable platform for in-depth exchange and mutual learning. Discussions spanned a wide range of topics, including hospital design and infrastructure, operational excellence, and innovative care delivery models. Both sides also explored potential synergies between the healthcare sectors in Saudi Arabia and China, highlighting opportunities for future collaboration.

A key theme throughout the dialogue was China’s rapidly growing role as a global hub for healthcare and life sciences innovation. This includes breakthroughs in advanced therapies such as CAR-T cell treatment, with the world’s first CAR-T therapy for solid tumors expected to become available in China in the first half of 2026. As part of this progress, Jiahui International Hospital will offer patients access to these cutting-edge cancer care solutions.

At the same time, the healthcare ecosystem in China is advancing rapidly in the deployment of artificial intelligence, including in areas such as radiology, where AI-supported diagnostics are enhancing accuracy, efficiency, and clinical decision-making. Together with continued progress in pharmaceuticals, medical technologies, and patient-centered care models, these developments underscore China’s growing global leadership in healthcare innovation.

As a leading international hospital in Shanghai, Jiahui International Hospital is proud to contribute to this momentum—serving not only as a provider of high-quality care, but also as a platform for international collaboration, knowledge exchange, and innovation.

We look forward to continuing the conversation and exploring opportunities to build meaningful partnerships that advance healthcare across borders.